Coronary artery bypass graft surgery (CABG) for patients with diabetes and multivessel coronary artery disease: Identifying patients who would benefit with CABG and understanding the potential mechanisms involved

Kevin L. Greason, Hartzell V Schaff

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Treatment of diabetic patients with multivessel coronary artery disease is controversial. This paper reviews pertinent literature on surgical revascularization with emphasis on which patients benefit from therapy. Recent studies of medical, percutaneous, and surgical therapies have added greatly to our understanding of the treatment of diabetic patients with coronary artery disease. Randomized trials show no advantage with prophylactic percutaneous coronary intervention over medical therapy. However, in patients with more severe three-vessel disease, coronary artery bypass graft surgery (CABG) improved outcomes with respect to reduced myocardial infarction events and cardiac death as compared with medical therapy. In addition, rates of late myocardial infarction and mortality were significantly lower in patients treated with CABG compared with those who received drug-eluting stents. Although the need for subsequent revascularization with drug-eluting stents is reduced compared with angioplasty and bare-metal stents, the rate is still higher than that associated with CABG. CABG reduces risks of myocardial infarction, cardiac death, and need for repeat revascularization in diabetic patients with severe, multivessel coronary artery disease.

Original languageEnglish (US)
Pages (from-to)402-406
Number of pages5
JournalCoronary Artery Disease
Volume21
Issue number7
DOIs
StatePublished - Nov 2010

Fingerprint

Coronary Artery Bypass
Coronary Artery Disease
Transplants
Drug-Eluting Stents
Myocardial Infarction
Therapeutics
Percutaneous Coronary Intervention
Angioplasty
Stents
Metals
Mortality

Keywords

  • coronary artery bypass graft
  • coronary artery disease
  • diabetes
  • medical therapy
  • percutaneous coronary intervention

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

@article{72c109c53f1a4ab3b9af20a9cc5c8cfa,
title = "Coronary artery bypass graft surgery (CABG) for patients with diabetes and multivessel coronary artery disease: Identifying patients who would benefit with CABG and understanding the potential mechanisms involved",
abstract = "Treatment of diabetic patients with multivessel coronary artery disease is controversial. This paper reviews pertinent literature on surgical revascularization with emphasis on which patients benefit from therapy. Recent studies of medical, percutaneous, and surgical therapies have added greatly to our understanding of the treatment of diabetic patients with coronary artery disease. Randomized trials show no advantage with prophylactic percutaneous coronary intervention over medical therapy. However, in patients with more severe three-vessel disease, coronary artery bypass graft surgery (CABG) improved outcomes with respect to reduced myocardial infarction events and cardiac death as compared with medical therapy. In addition, rates of late myocardial infarction and mortality were significantly lower in patients treated with CABG compared with those who received drug-eluting stents. Although the need for subsequent revascularization with drug-eluting stents is reduced compared with angioplasty and bare-metal stents, the rate is still higher than that associated with CABG. CABG reduces risks of myocardial infarction, cardiac death, and need for repeat revascularization in diabetic patients with severe, multivessel coronary artery disease.",
keywords = "coronary artery bypass graft, coronary artery disease, diabetes, medical therapy, percutaneous coronary intervention",
author = "Greason, {Kevin L.} and Schaff, {Hartzell V}",
year = "2010",
month = "11",
doi = "10.1097/MCA.0b013e32833bfde3",
language = "English (US)",
volume = "21",
pages = "402--406",
journal = "Coronary Artery Disease",
issn = "0954-6928",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - Coronary artery bypass graft surgery (CABG) for patients with diabetes and multivessel coronary artery disease

T2 - Identifying patients who would benefit with CABG and understanding the potential mechanisms involved

AU - Greason, Kevin L.

AU - Schaff, Hartzell V

PY - 2010/11

Y1 - 2010/11

N2 - Treatment of diabetic patients with multivessel coronary artery disease is controversial. This paper reviews pertinent literature on surgical revascularization with emphasis on which patients benefit from therapy. Recent studies of medical, percutaneous, and surgical therapies have added greatly to our understanding of the treatment of diabetic patients with coronary artery disease. Randomized trials show no advantage with prophylactic percutaneous coronary intervention over medical therapy. However, in patients with more severe three-vessel disease, coronary artery bypass graft surgery (CABG) improved outcomes with respect to reduced myocardial infarction events and cardiac death as compared with medical therapy. In addition, rates of late myocardial infarction and mortality were significantly lower in patients treated with CABG compared with those who received drug-eluting stents. Although the need for subsequent revascularization with drug-eluting stents is reduced compared with angioplasty and bare-metal stents, the rate is still higher than that associated with CABG. CABG reduces risks of myocardial infarction, cardiac death, and need for repeat revascularization in diabetic patients with severe, multivessel coronary artery disease.

AB - Treatment of diabetic patients with multivessel coronary artery disease is controversial. This paper reviews pertinent literature on surgical revascularization with emphasis on which patients benefit from therapy. Recent studies of medical, percutaneous, and surgical therapies have added greatly to our understanding of the treatment of diabetic patients with coronary artery disease. Randomized trials show no advantage with prophylactic percutaneous coronary intervention over medical therapy. However, in patients with more severe three-vessel disease, coronary artery bypass graft surgery (CABG) improved outcomes with respect to reduced myocardial infarction events and cardiac death as compared with medical therapy. In addition, rates of late myocardial infarction and mortality were significantly lower in patients treated with CABG compared with those who received drug-eluting stents. Although the need for subsequent revascularization with drug-eluting stents is reduced compared with angioplasty and bare-metal stents, the rate is still higher than that associated with CABG. CABG reduces risks of myocardial infarction, cardiac death, and need for repeat revascularization in diabetic patients with severe, multivessel coronary artery disease.

KW - coronary artery bypass graft

KW - coronary artery disease

KW - diabetes

KW - medical therapy

KW - percutaneous coronary intervention

UR - http://www.scopus.com/inward/record.url?scp=78049292180&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78049292180&partnerID=8YFLogxK

U2 - 10.1097/MCA.0b013e32833bfde3

DO - 10.1097/MCA.0b013e32833bfde3

M3 - Article

C2 - 20706113

AN - SCOPUS:78049292180

VL - 21

SP - 402

EP - 406

JO - Coronary Artery Disease

JF - Coronary Artery Disease

SN - 0954-6928

IS - 7

ER -